<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37083877</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-6307</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Current rheumatology reports</Title><ISOAbbreviation>Curr Rheumatol Rep</ISOAbbreviation></Journal><ArticleTitle>Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus.</ArticleTitle><Pagination><StartPage>107</StartPage><EndPage>116</EndPage><MedlinePgn>107-116</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11926-023-01102-z</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by various autoantibodies and multi-organ. Microbiota dysbiosis in the gut, skin, oral, and other surfaces has a significant impact on SLE development. This article summarizes relevant research and provides new microbiome-related strategies for exploring the mechanisms and treating patients with SLE.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">SLE patients have disruptions in multiple microbiomes, with the gut microbiota (bacteria, viruses, and fungi) and their metabolites being the most thoroughly researched. This dysbiosis can promote SLE progression through mechanisms such as the leaky gut, molecular mimicry, and epigenetic regulation. Notwithstanding study constraints on the relationship between microbiota and SLE, specific interventions targeting the gut microbiota, such as probiotics, dietary management, and fecal microbiota transplantation, have emerged as promising SLE therapeutics.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lei</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Qianmei</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qilin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China. zhaoming301@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China. zhaoming301@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China. zhaoming301@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China. zhaoming301@pumcderm.cams.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lu</LastName><ForeName>Qianjin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022YFC3601800</GrantID><Agency>National Key R&amp;D Program of China</Agency><Country/></Grant><Grant><GrantID>No.2021-I2M-1-059</GrantID><Agency>CAMS Innovation Fund of Medical Sciences</Agency><Country/></Grant><Grant><GrantID>2020-RC320-003</GrantID><Agency>Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences</Agency><Country/></Grant><Grant><GrantID>NO. 81830097</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>NO. 32141004</GrantID><Agency>Special Program of National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Rheumatol Rep</MedlineTA><NlmUniqueID>100888970</NlmUniqueID><ISSNLinking>1523-3774</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Dysbiosis</Keyword><Keyword MajorTopicYN="N">Microbiota</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>21</Day><Hour>14</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37083877</ArticleId><ArticleId IdType="doi">10.1007/s11926-023-01102-z</ArticleId><ArticleId IdType="pii">10.1007/s11926-023-01102-z</ArticleId></ArticleIdList><ReferenceList><ReferenceList><Title>Papers of particular interest, published recently, have been highlighted as: &#x2022; Of importance &#x2022;&#x2022; Of major importance</Title><Reference><Citation>Dominguez-Bello MG, Godoy-Vitorino F, Knight R, Blaser MJ. Role of the microbiome in human development. Gut. 2019;68(6):1108&#x2013;14. https://doi.org/10.1136/gutjnl-2018-317503 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2018-317503</ArticleId><ArticleId IdType="pubmed">30670574</ArticleId></ArticleIdList></Reference><Reference><Citation>Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207&#x2013;14. https://doi.org/10.1038/nature11234 .</Citation></Reference><Reference><Citation>Kishikawa T, Maeda Y, Nii T, Motooka D, Matsumoto Y, Matsushita M, et al. Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population. Ann Rheum Dis. 2020;79(1):103&#x2013;11. https://doi.org/10.1136/annrheumdis-2019-215743 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215743</ArticleId><ArticleId IdType="pubmed">31699813</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen BD, Jia XM, Xu JY, Zhao LD, Ji JY, Wu BX, et al. An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arthritis Rheumatology (Hoboken, NJ). 2021;73(2):232&#x2013;43. https://doi.org/10.1002/art.41511 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41511</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishikawa T, Ogawa K, Motooka D, Hosokawa A, Kinoshita M, Suzuki K, et al. A metagenome-wide association study of gut microbiome in patients with multiple sclerosis revealed novel disease pathology. Front Cell Infect Microbiol. 2020;10:585973. https://doi.org/10.3389/fcimb.2020.585973 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.585973</ArticleId><ArticleId IdType="pubmed">33363050</ArticleId><ArticleId IdType="pmc">7759502</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano-Ortiz A, Laborda-Illanes A, Plaza-Andrades I, Membrillo Del Pozo A, Villarrubia Cuadrado A, Rodr&#xed;guez Calvo de Mora M, et al. Connection between the gut microbiome, systemic inflammation, gut permeability and FOXP3 expression in patients with primary Sj&#xf6;gren&#x2019;s syndrome. International Journal of Molecular Sciences. 2020;21(22). https://doi.org/10.3390/ijms21228733 .</Citation></Reference><Reference><Citation>Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update &#x3bf;n the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80(1):14&#x2013;25. https://doi.org/10.1136/annrheumdis-2020-218272 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218272</ArticleId><ArticleId IdType="pubmed">33051219</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo JMP, Parks CG, Jacobsen S, Costenbader KH, Bernatsky S. The role of environmental exposures and gene-environment interactions in the etiology of systemic lupus erythematous. J Intern Med. 2022;291(6):755&#x2013;78. https://doi.org/10.1111/joim.13448 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13448</ArticleId><ArticleId IdType="pubmed">35143075</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang HF, Li X, Li HX, Zhang Q, Zhou HW, et al. 2019 Disordered intestinal microbes are associated with the activity of systemic lupus erythematosus. Clinical science (London, England : 1979) 133(7):821&#x2013;38. https://doi.org/10.1042/cs20180841 .</Citation></Reference><Reference><Citation>Zhou HY, Cao NW, Guo B, Chen WJ, Tao JH, Chu XJ, et al. Systemic lupus erythematosus patients have a distinct structural and functional skin microbiota compared with controls. Lupus. 2021;30(10):1553&#x2013;64. https://doi.org/10.1177/09612033211025095 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211025095</ArticleId><ArticleId IdType="pubmed">34139926</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Ren T, Li X, Zhai Q, Xu X, Zhang N, et al. Distinct microbiomes of gut and saliva in patients with systemic lupus erythematous and clinical associations. Front Immunol. 2021;12:626217. https://doi.org/10.3389/fimmu.2021.626217 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.626217</ArticleId><ArticleId IdType="pubmed">34276643</ArticleId><ArticleId IdType="pmc">8281017</ArticleId></ArticleIdList></Reference><Reference><Citation>James WA, Ogunrinde E, Wan Z, Kamen DL, Oates J, Gilkeson GS, et al. A distinct plasma microbiome but not gut microbiome in patients with systemic lupus erythematosus compared to healthy individuals. J Rheumatol. 2022;49(6):592&#x2013;7. https://doi.org/10.3899/jrheum.210952 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.210952</ArticleId><ArticleId IdType="pubmed">35169056</ArticleId><ArticleId IdType="pmc">9364828</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomaa EZ. Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek. 2020;113(12):2019&#x2013;40. https://doi.org/10.1007/s10482-020-01474-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10482-020-01474-7</ArticleId><ArticleId IdType="pubmed">33136284</ArticleId></ArticleIdList></Reference><Reference><Citation>Heintz-Buschart A, Wilmes P. Human gut microbiome: function matters. Trends Microbiol. 2018;26(7):563&#x2013;74. https://doi.org/10.1016/j.tim.2017.11.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2017.11.002</ArticleId><ArticleId IdType="pubmed">29173869</ArticleId></ArticleIdList></Reference><Reference><Citation>Hevia A, Milani C, L&#xf3;pez P, Cuervo A, Arboleya S, Duranti S, et al. 2014 Intestinal dysbiosis associated with systemic lupus erythematosus. mBio (5):01548&#x2013;14. https://doi.org/10.1128/mBio.01548-14 .</Citation></Reference><Reference><Citation>Xiang K, Wang P, Xu Z, Hu YQ, He YS, Chen Y, et al. Causal effects of gut microbiome on systemic lupus erythematosus: a two-sample mendelian randomization study. Front Immunol. 2021;12:667097. https://doi.org/10.3389/fimmu.2021.667097 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.667097</ArticleId><ArticleId IdType="pubmed">34557183</ArticleId><ArticleId IdType="pmc">8453215</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, Ni JJ, Han BX, Yan SS, Wei XT, Feng GJ, et al. Causal relationship between gut microbiota and autoimmune diseases: a two-sample Mendelian randomization study. Front Immunol. 2021;12:746998. https://doi.org/10.3389/fimmu.2021.746998 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746998</ArticleId><ArticleId IdType="pubmed">35140703</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Shao T, Li H, Xie Z, Wen C. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut pathogens. 2016;8:64. https://doi.org/10.1186/s13099-016-0146-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-016-0146-9</ArticleId><ArticleId IdType="pubmed">27980687</ArticleId><ArticleId IdType="pmc">5146896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wei J, Zhang W, Doherty M, Zhang Y, Xie H, et al. Gut dysbiosis in rheumatic diseases: a systematic review and meta-analysis of 92 observational studies. EBioMedicine. 2022;80:104055. https://doi.org/10.1016/j.ebiom.2022.104055 This article conducted a systematic review in various rheumatic diseases and identified similarities and differences among these diseases</Citation></Reference><Reference><Citation>Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Annals of the rheumatic diseases. 2019;78(7):947-56. https://doi.org/10.1136/annrheumdis-2018-214856 The article revealed that Ruminococcus gnavus contributes to the pathogenesis of lupus nephritis by molecular mimicry.</Citation></Reference><Reference><Citation>Wen M, Liu T, Zhao M, Dang X, Feng S, Ding X, et al. Correlation Analysis between gut microbiota and metabolites in children with systemic lupus erythematosus. J Immunol Res. 2021;2021:5579608. https://doi.org/10.1155/2021/5579608 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5579608</ArticleId><ArticleId IdType="pubmed">34341764</ArticleId><ArticleId IdType="pmc">8325587</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago-Rodriguez TM, Hollister EB. Human virome and disease: high-throughput sequencing for virus discovery, identification of phage-bacteria dysbiosis and development of therapeutic approaches with emphasis on the human gut. Viruses. 2019;11(7). https://doi.org/10.3390/v11070656 .</Citation></Reference><Reference><Citation>Dutilh BE, Cassman N, McNair K, Sanchez SE, Silva GG, Boling L, et al. A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes. Nat Commun. 2014;5:4498. https://doi.org/10.1038/ncomms5498 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5498</ArticleId><ArticleId IdType="pubmed">25058116</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Yan Q, Yao X, Li S, Lv Q, Wang G, et al. Alterations of the gut virome in patients with systemic lupus erythematosus. Front Immunol. 2022;13:1050895. https://doi.org/10.3389/fimmu.2022.1050895 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1050895</ArticleId><ArticleId IdType="pubmed">36713446</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomofuji Y, Kishikawa T, Maeda Y, Ogawa K, Nii T, Okuno T, et al. Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease. Annals of the rheumatic diseases. 2022;81(2):278-88. https://doi.org/10.1136/annrheumdis-2021-221267 This article filled the gap in the study of viruses in the autoimmunity associated gut microbiome.</Citation></Reference><Reference><Citation>d'Enfert C, Kaune AK, Alaban LR, Chakraborty S, Cole N, Delavy M, et al. The impact of the fungus-host-microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS microbiology reviews. 2021;45(3). https://doi.org/10.1093/femsre/fuaa060 .</Citation></Reference><Reference><Citation>Lapiere A, Richard ML. Bacterial-fungal metabolic interactions within the microbiota and their potential relevance in human health and disease: a short review. Gut microbes. 2022;14(1):2105610. https://doi.org/10.1080/19490976.2022.2105610 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2022.2105610</ArticleId><ArticleId IdType="pubmed">35903007</ArticleId><ArticleId IdType="pmc">9341359</ArticleId></ArticleIdList></Reference><Reference><Citation>Guinan J, Wang S, Hazbun TR, Yadav H, Thangamani S. Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans. Sci Rep. 2019;9(1):8872. https://doi.org/10.1038/s41598-019-45467-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-45467-7</ArticleId><ArticleId IdType="pubmed">31222159</ArticleId><ArticleId IdType="pmc">6586901</ArticleId></ArticleIdList></Reference><Reference><Citation>Doron I, Mesko M, Li XV, Kusakabe T, Leonardi I, Shaw DG, et al. Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn&#x2019;s disease. Nat Microbiol. 2021;6(12):1493&#x2013;504. https://doi.org/10.1038/s41564-021-00983-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00983-z</ArticleId><ArticleId IdType="pubmed">34811531</ArticleId><ArticleId IdType="pmc">8622360</ArticleId></ArticleIdList></Reference><Reference><Citation>Li BZ, Wang H, Li XB, Zhang QR, Huang RG, Wu H, et al. Altered gut fungi in systemic lupus erythematosus - a pilot study. Front Microbiol. 2022;13:1031079. https://doi.org/10.3389/fmicb.2022.1031079 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1031079</ArticleId><ArticleId IdType="pubmed">36545195</ArticleId><ArticleId IdType="pmc">9760866</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YF, Hsieh AH, Wang LC, Huang YJ, Yun-Chen T, Tseng WY, et al. Fecal microbiota changes in NZB/W F1 mice after induction of lupus disease. Sci Rep. 2021;11(1):22953. https://doi.org/10.1038/s41598-021-02422-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-02422-9</ArticleId><ArticleId IdType="pubmed">34824318</ArticleId><ArticleId IdType="pmc">8616951</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo XM, Edwards MR, Mu Q, Yu Y, Vieson MD, Reilly CM, et al. Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Applied and environmental microbiology. 2018;84(4). https://doi.org/10.1128/aem.02288-17 .</Citation></Reference><Reference><Citation>Zhang H, Liao X, Sparks JB, Luo XM. Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol. 2014;80(24):7551&#x2013;60. https://doi.org/10.1128/aem.02676-14 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aem.02676-14</ArticleId><ArticleId IdType="pubmed">25261516</ArticleId><ArticleId IdType="pmc">4249226</ArticleId></ArticleIdList></Reference><Reference><Citation>Zegarra-Ruiz DF, El Beidaq A, I&#xf1;iguez AJ, Lubrano Di Ricco M, Manfredo Vieira S, Ruff WE, et al. 2019 A diet-sensitive commensal Lactobacillus strain mediates TLR7-dependent systemic autoimmunity. Cell host &amp; microbe. (1):113&#x2013;27.6 https://doi.org/10.1016/j.chom.2018.11.009</Citation></Reference><Reference><Citation>Toumi E, Goutorbe B, Plauzolles A, Bonnet M, Mezouar S, Militello M, et al. Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery. Front Immunol. 2022;13:943241. https://doi.org/10.3389/fimmu.2022.943241 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.943241</ArticleId><ArticleId IdType="pubmed">35983031</ArticleId><ArticleId IdType="pmc">9378784</ArticleId></ArticleIdList></Reference><Reference><Citation>Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):1002533. https://doi.org/10.1371/journal.pbio.1002533 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff WE, Greiling TM, Kriegel MA. Host-microbiota interactions in immune-mediated diseases. Nat Rev Microbiol. 2020;18(9):521&#x2013;38. https://doi.org/10.1038/s41579-020-0367-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-0367-2</ArticleId><ArticleId IdType="pubmed">32457482</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Yi X, Long H, Zhang G, Wu H, Zhao M, et al. Disordered cutaneous microbiota in systemic lupus erythematosus. J Autoimmun. 2020;108:102391. https://doi.org/10.1016/j.jaut.2019.102391 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102391</ArticleId><ArticleId IdType="pubmed">31883828</ArticleId></ArticleIdList></Reference><Reference><Citation>Terui H, Yamasaki K, Wada-Irimada M, Onodera-Amagai M, Hatchome N, Mizuashi M, et al. Staphylococcus aureus skin colonization promotes SLE-like autoimmune inflammation via neutrophil activation and the IL-23/IL-17 axis. Sci Immunol. 2022;7(76):9811. https://doi.org/10.1126/sciimmunol.abm9811 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abm9811</ArticleId></ArticleIdList></Reference><Reference><Citation>Paetzold B, Willis JR, Pereira de Lima J, Kn&#xf6;dlseder N, Br&#xfc;ggemann H, Quist SR, et al. Skin microbiome modulation induced by probiotic solutions. Microbiome. 2019;7(1):95. https://doi.org/10.1186/s40168-019-0709-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-019-0709-3</ArticleId><ArticleId IdType="pubmed">31234928</ArticleId><ArticleId IdType="pmc">6591853</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol. 2018;200(4):525&#x2013;40. https://doi.org/10.1007/s00203-018-1505-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00203-018-1505-3</ArticleId><ArticleId IdType="pubmed">29572583</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudsi M, Nahas LD, Alsawah R, Hamsho A, Omar A. The prevalence of oral mucosal lesions and related factors in systemic lupus erythematosus patients. Arthritis Res Ther. 2021;23(1):229. https://doi.org/10.1186/s13075-021-02614-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02614-8</ArticleId><ArticleId IdType="pubmed">34479636</ArticleId><ArticleId IdType="pmc">8414847</ArticleId></ArticleIdList></Reference><Reference><Citation>Corr&#xea;a JD, Calderaro DC, Ferreira GA, Mendon&#xe7;a SM, Fernandes GR, Xiao E, et al. Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status. Microbiome. 2017;5(1):34. https://doi.org/10.1186/s40168-017-0252-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0252-z</ArticleId><ArticleId IdType="pubmed">28320468</ArticleId><ArticleId IdType="pmc">5359961</ArticleId></ArticleIdList></Reference><Reference><Citation>Malcolm J, Awang RA, Oliver-Bell J, Butcher JP, Campbell L, AdradosPlanell A, et al. IL-33 Exacerbates periodontal disease through induction of RANKL. J Dent Res. 2015;94(7):968&#x2013;75. https://doi.org/10.1177/0022034515577815 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034515577815</ArticleId><ArticleId IdType="pubmed">25808546</ArticleId></ArticleIdList></Reference><Reference><Citation>Dassi E, Ferretti P, Covello G, Bertorelli R, Denti MA, De Sanctis V, et al. The short-term impact of probiotic consumption on the oral cavity microbiome. Sci Rep. 2018;8(1):10476. https://doi.org/10.1038/s41598-018-28491-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28491-x</ArticleId><ArticleId IdType="pubmed">29992994</ArticleId><ArticleId IdType="pmc">6041349</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaura E, Brandt BW, Teixeira de Mattos MJ, Buijs MJ, Caspers MP, Rashid MU, et al. Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces. Bio. 2015;6:01693&#x2013;715. https://doi.org/10.1128/mBio.01693-15 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01693-15</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo DJ, Rifkin RF, Cowan DA, Potgieter M. The healthy human blood microbiome: fact or fiction? Front Cell Infect Microbiol. 2019;9:148. https://doi.org/10.3389/fcimb.2019.00148 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00148</ArticleId><ArticleId IdType="pubmed">31139578</ArticleId><ArticleId IdType="pmc">6519389</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Alekseyenko AV, Ogunrinde E, Li M, Li QZ, Huang L, et al. Rigorous plasma microbiome analysis method enables disease association discovery in clinic. Front Microbiol. 2020;11:613268. https://doi.org/10.3389/fmicb.2020.613268 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.613268</ArticleId><ArticleId IdType="pubmed">33488555</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunrinde E, Zhou Z, Luo Z, Alekseyenko A, Li QZ, Macedo D, et al. A link between plasma microbial translocation, microbiome, and autoantibody development in first-degree relatives of systemic lupus erythematosus patients. Arthritis &amp; rheumatology (Hoboken, NJ). 2019;71(11):1858-68. https://doi.org/10.1002/art.40935 This study showed a possible role of plasma microbial translocation in influencing autoantibody development in SLE.</Citation></Reference><Reference><Citation>Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol. 2012;30:149&#x2013;73. https://doi.org/10.1146/annurev-immunol-020711-075001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-020711-075001</ArticleId><ArticleId IdType="pubmed">22224779</ArticleId><ArticleId IdType="pmc">3513328</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanford JA, Gallo RL. Functions of the skin microbiota in health and disease. Semin Immunol. 2013;25(5):370&#x2013;7. https://doi.org/10.1016/j.smim.2013.09.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2013.09.005</ArticleId><ArticleId IdType="pubmed">24268438</ArticleId><ArticleId IdType="pmc">4219649</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes L, Herrera D, Kozarov E, Rold&#xe1;n S, Progulske-Fox A. Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology. J Clin Periodontol. 2013;40(Suppl 14):S30-50. https://doi.org/10.1111/jcpe.12079 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12079</ArticleId><ArticleId IdType="pubmed">23627333</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaco DR, Kottapalli SV, Breitwieser FP, Anderson DE, Wijaya L, Tan K, et al. Deconvoluting virome-wide antibody epitope reactivity profiles. EBioMedicine. 2022;75:103747. https://doi.org/10.1016/j.ebiom.2021.103747 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103747</ArticleId><ArticleId IdType="pubmed">34922324</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020;76(2):265&#x2013;81. https://doi.org/10.1053/j.ajkd.2019.10.017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2019.10.017</ArticleId><ArticleId IdType="pubmed">32220510</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Du J, Zhai Q, Hu J, Miller AW, Ren T, et al. The Bladder microbiome, metabolome, cytokines, and phenotypes in patients with systemic lupus erythematosus. Microbiol Spectrum. 2022;10(5):0021222. https://doi.org/10.1128/spectrum.00212-22 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00212-22</ArticleId></ArticleIdList></Reference><Reference><Citation>Spadoni I, Zagato E, Bertocchi A, Paolinelli R, Hot E, Di Sabatino A, et al. A gut-vascular barrier controls the systemic dissemination of bacteria. Science (New York, NY). 2015;350(6262):830&#x2013;4. https://doi.org/10.1126/science.aad0135 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad0135</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Q, Kirby J, Reilly CM, Luo XM. Leaky gut as a danger signal for autoimmune diseases. Front Immunol. 2017;8:598. https://doi.org/10.3389/fimmu.2017.00598 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00598</ArticleId><ArticleId IdType="pubmed">28588585</ArticleId><ArticleId IdType="pmc">5440529</ArticleId></ArticleIdList></Reference><Reference><Citation>Saithong S, Saisorn W, Visitchanakun P, Sae-Khow K, Chiewchengchol D, Leelahavanichkul A. A synergy between endotoxin and (1&#x2192;3)-beta-D-glucan enhanced neutrophil extracellular traps in candida administered dextran sulfate solution induced colitis in FcGRIIB-/- lupus mice, an Impact of intestinal fungi in lupus. J Inflamm Res. 2021;14:2333&#x2013;52. https://doi.org/10.2147/jir.S305225 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jir.S305225</ArticleId><ArticleId IdType="pubmed">34103965</ArticleId><ArticleId IdType="pmc">8179808</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science (New York, NY). 2018;359(6380):1156&#x2013;61. https://doi.org/10.1126/science.aar7201 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar7201</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol. 2012;42(1):71&#x2013;8. https://doi.org/10.1007/s12016-011-8291-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-011-8291-x</ArticleId><ArticleId IdType="pubmed">22109896</ArticleId></ArticleIdList></Reference><Reference><Citation>McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005;11(1):85&#x2013;9. https://doi.org/10.1038/nm1167 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1167</ArticleId><ArticleId IdType="pubmed">15619631</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiling TM, Dehner C, Chen X, Hughes K, I&#xf1;iguez AJ, Boccitto M, et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med. 2018;10(434). https://doi.org/10.1126/scitranslmed.aan2306 .</Citation></Reference><Reference><Citation>Zhang SX, Wang J, Chen JW, Zhang MX, Zhang YF, Hu FY, et al. The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus. Annals Rheumatic Dis. 2021;80(11):177. https://doi.org/10.1136/annrheumdis-2019-216504 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-216504</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez P, de Paz B, Rodr&#xed;guez-Carrio J, Hevia A, S&#xe1;nchez B, Margolles A, et al. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci Rep. 2016;6:24072. https://doi.org/10.1038/srep24072 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24072</ArticleId><ArticleId IdType="pubmed">27044888</ArticleId><ArticleId IdType="pmc">4820712</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirakashi M, Maruya M, Hirota K, Tsuruyama T, Matsuo T, Watanabe R, et al. Effect of impaired T cell receptor signaling on the gut microbiota in a mouse model of systemic autoimmunity. Arthritis &amp; rheumatology (Hoboken, NJ). 2022;74(4):641&#x2013;53. https://doi.org/10.1002/art.42016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42016</ArticleId></ArticleIdList></Reference><Reference><Citation>Zouali M. B lymphocytes, the gastrointestinal tract and autoimmunity. Autoimmunity reviews. 2021;20(4):102777. https://doi.org/10.1016/j.autrev.2021.102777 .</Citation></Reference><Reference><Citation>Bunker JJ, Drees C, Watson AR, Plunkett CH, Nagler CR, Schneewind O, et al. B cell superantigens in the human intestinal microbiota. Sci Transl Med. 2019;11(507). https://doi.org/10.1126/scitranslmed.aau9356 .</Citation></Reference><Reference><Citation>Thio CL, Chi PY, Lai AC, Chang YJ. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate. J Allergy Clin Immunol. 2018;142(6):1867-83.e12. https://doi.org/10.1016/j.jaci.2018.02.032 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.02.032</ArticleId><ArticleId IdType="pubmed">29522844</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, Jiang S, Qian D, Duan J. Modulation of microbially derived short-chain fatty acids on intestinal homeostasis, metabolism, and neuropsychiatric disorder. Appl Microbiol Biotechnol. 2020;104(2):589&#x2013;601. https://doi.org/10.1007/s00253-019-10312-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-019-10312-4</ArticleId><ArticleId IdType="pubmed">31865438</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez HN, Moroney JB, Gan H, Shen T, Im JL, Li T, et al. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids. Nature communications. 2020;11(1):60. https://doi.org/10.1038/s41467-019-13603-6 This study demonstrated the impact of SCFA on B cell by epigenetic modulation.</Citation></Reference><Reference><Citation>Liu Y, Hou Y, Wang G, Zheng X, Hao H. Gut microbial metabolites of aromatic amino acids as signals in host-microbe interplay. Trends Endocrinol Metab. 2020;31(11):818&#x2013;34. https://doi.org/10.1016/j.tem.2020.02.012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2020.02.012</ArticleId><ArticleId IdType="pubmed">32284282</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Pang T, Lin Z, Zhao M, Jin H. The key player in the pathogenesis of environmental influence of systemic lupus erythematosus: Aryl hydrocarbon receptor. Front Immunol. 2022;13:965941. https://doi.org/10.3389/fimmu.2022.965941 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.965941</ArticleId><ArticleId IdType="pubmed">36110860</ArticleId><ArticleId IdType="pmc">9468923</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SC, Brown J, Gong M, Ge Y, Zadeh M, Li W, et al. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice. Sci Transl Med. 2020;12(551). https://doi.org/10.1126/scitranslmed.aax2220 .</Citation></Reference><Reference><Citation>Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32(6):815&#x2013;27. https://doi.org/10.1016/j.immuni.2010.06.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.06.001</ArticleId><ArticleId IdType="pubmed">20620945</ArticleId><ArticleId IdType="pmc">2904693</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong H, Alduraibi F, Ponder D, Duck WL, Morrow CD, Foote JB, et al. Host genetics but not commensal microbiota determines the initial development of systemic autoimmune disease in BXD2 mice. Arthritis &amp; rheumatology (Hoboken, NJ). 2022;74(4):634&#x2013;40. https://doi.org/10.1002/art.42008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42008</ArticleId></ArticleIdList></Reference><Reference><Citation>Clancy RM, Marion MC, Ainsworth HC, Chang M, Howard TD, Izmirly PM, et al. Gut dysbiosis and the clinical spectrum in anti-Ro positive mothers of children with neonatal lupus. Gut microbes. 2022;14(1):2081474. https://doi.org/10.1080/19490976.2022.2081474 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2022.2081474</ArticleId><ArticleId IdType="pubmed">35704681</ArticleId><ArticleId IdType="pmc">9225419</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang S, Qu Y, Qian S, Wang R, Wang Y, Jin Y, et al. Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis. Lupus science &amp; medicine. 2022;9(1). https://doi.org/10.1136/lupus-2021-000599 .</Citation></Reference><Reference><Citation>Jackson MA, Verdi S, Maxan ME, Shin CM, Zierer J, Bowyer RCE, et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort. Nat Commun. 2018;9(1):2655. https://doi.org/10.1038/s41467-018-05184-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05184-7</ArticleId><ArticleId IdType="pubmed">29985401</ArticleId><ArticleId IdType="pmc">6037668</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Kong X, Shao T, Zhang Y, Wen C. Alterations of the gut microbiota associated with promoting efficacy of prednisone by bromofuranone in MRL/lpr mice. Front Microbiol. 2019;10:978. https://doi.org/10.3389/fmicb.2019.00978 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.00978</ArticleId><ArticleId IdType="pubmed">31118928</ArticleId><ArticleId IdType="pmc">6504707</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Wang H, Xu S, Zhuang Y, An J, Su C, et al. Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut microbes. 2020;11(6):1758&#x2013;73. https://doi.org/10.1080/19490976.2020.1768644 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1768644</ArticleId><ArticleId IdType="pubmed">32507008</ArticleId><ArticleId IdType="pmc">7524333</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Zhu Z, Lin X, Li H, Wen C, Bao J, et al. Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL/lpr mice. Arthritis Res Ther. 2021;23(1):240. https://doi.org/10.1186/s13075-021-02620-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02620-w</ArticleId><ArticleId IdType="pubmed">34521450</ArticleId><ArticleId IdType="pmc">8439074</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan ZY, Chang YX, Han N, Hou FY, Lee BJY, Zhi FC, et al. Short-term high-dose gavage of hydroxychloroquine changes gut microbiota but not the intestinal integrity and immunological responses in mice. Life Sci. 2021;264:118450. https://doi.org/10.1016/j.lfs.2020.118450 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118450</ArticleId><ArticleId IdType="pubmed">33131749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SK, Guevarra RB, Kim YT, Kwon J, Kim H, Cho JH, et al. Role of probiotics in human gut microbiome-associated diseases. J Microbiol Biotechnol. 2019;29(9):1335&#x2013;40. https://doi.org/10.4014/jmb.1906.06064 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4014/jmb.1906.06064</ArticleId><ArticleId IdType="pubmed">31434172</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Niu Z, Zou M, Liu S, Wang M, Gu X, et al. Probiotics, prebiotics, and synbiotics regulate the intestinal microbiota differentially and restore the relative abundance of specific gut microorganisms. J Dairy Sci. 2020;103(7):5816&#x2013;29. https://doi.org/10.3168/jds.2019-18003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3168/jds.2019-18003</ArticleId><ArticleId IdType="pubmed">32418689</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Q, Zhang H, Liao X, Lin K, Liu H, Edwards MR, et al. Control of lupus nephritis by changes of gut microbiota. Microbiome. 2017;5(1):73. https://doi.org/10.1186/s40168-017-0300-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0300-8</ArticleId><ArticleId IdType="pubmed">28697806</ArticleId><ArticleId IdType="pmc">5505136</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu TC, Huang CY, Liu CH, Hsu KC, Chen YH, Tzang BS. Lactobacillus paracasei GMNL-32, Lactobacillus reuteri GMNL-89 and L reuteri GMNL-263 ameliorate hepatic injuries in lupus-prone mice. British J Nutri. 2017;117(8):1066&#x2013;74. https://doi.org/10.1017/s0007114517001039 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s0007114517001039</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu WS, Rajendran P, Tzang BS, Yeh YL, Shen CY, Chen RJ, et al. Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice. PLoS ONE. 2017;12(9):0185098. https://doi.org/10.1371/journal.pone.0185098 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0185098</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh YL, Lu MC, Tsai BC, Tzang BS, Cheng SM, Zhang X, et al. Heat-killed Lactobacillus reuteri GMNL-263 inhibits systemic lupus erythematosus-induced cardiomyopathy in NZB/W F1 mice. Probiotics and antimicrobial proteins. 2021;13(1):51&#x2013;9. https://doi.org/10.1007/s12602-020-09668-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12602-020-09668-1</ArticleId><ArticleId IdType="pubmed">32514746</ArticleId></ArticleIdList></Reference><Reference><Citation>Widhani A, Djauzi S, Suyatna FD, Dewi BE. Changes in gut microbiota and systemic inflammation after synbiotic supplementation in patients with systemic lupus erythematosus: a randomized, double-blind, placebo-controlled trial. Cells. 2022;11(21). https://doi.org/10.3390/cells11213419 .</Citation></Reference><Reference><Citation>Sch&#xe4;fer AL, Eichhorst A, Hentze C, Kraemer AN, Amend A, Sprenger DTL, et al. Low dietary fiber intake links development of obesity and lupus pathogenesis. Front Immunol. 2021;12:696810. https://doi.org/10.3389/fimmu.2021.696810 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.696810</ArticleId><ArticleId IdType="pubmed">34335609</ArticleId><ArticleId IdType="pmc">8320762</ArticleId></ArticleIdList></Reference><Reference><Citation>Putri PZ, Hamijoyo L, Sahiratmadja E. The role of diet in influencing the diversity of gut microbiome related to lupus disease activities: a systematic review. Int J Microbiol. 2022;2022:6908677. https://doi.org/10.1155/2022/6908677 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/6908677</ArticleId><ArticleId IdType="pubmed">36624775</ArticleId><ArticleId IdType="pmc">9825236</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MA, Khandker SS, Kotyla PJ, Hassan R. Immunomodulatory effects of diet and nutrients in systemic lupus erythematosus (SLE): a systematic review. Front Immunol. 2020;11:1477. https://doi.org/10.3389/fimmu.2020.01477 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01477</ArticleId><ArticleId IdType="pubmed">32793202</ArticleId><ArticleId IdType="pmc">7387408</ArticleId></ArticleIdList></Reference><Reference><Citation>Quraishi MN, Widlak M, Bhala N, Moore D, Price M, Sharma N, et al. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther. 2017;46(5):479&#x2013;93. https://doi.org/10.1111/apt.14201 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.14201</ArticleId><ArticleId IdType="pubmed">28707337</ArticleId></ArticleIdList></Reference><Reference><Citation>Watane A, Cavuoto KM, Rojas M, Dermer H, Day JO, Banerjee S, et al. Fecal microbial transplant in individuals with immune-mediated dry eye. Am J Ophthalmol. 2022;233:90&#x2013;100. https://doi.org/10.1016/j.ajo.2021.06.022 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2021.06.022</ArticleId><ArticleId IdType="pubmed">34214453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Xu X, Li M, Cai J, Wei Q, Niu H. Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus. Mole Med (Cambridge, Mass). 2019;25(1):35. https://doi.org/10.1186/s10020-019-0102-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-019-0102-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Yi P, Zhu M, Zhou W, Zhang B, Yi X, et al. Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: an EXPLORER trial. J autoimmunity. 2022;130:102844. https://doi.org/10.1016/j.jaut.2022.102844 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102844</ArticleId></ArticleIdList></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>